• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

Cognitive dysfunction in pediatric- vs. adult-onset MS

September 11, 2014  

Spinal taps prognostic in CIS

September 11, 2014  

Trend to earlier, more aggressive therapy: U.S. survey

September 11, 2014  

Atacicept: the aftermath

September 3, 2014  

New dosing for glatiramer acetate

August 6, 2014  

MS patient website tops 70,000 visits

June 3, 2014  

The time course of MS – AudioSlide presentation

May 28, 2014  

Alemtuzumab receives Health Canada approval

April 23, 2014  

MS treatment failure: who is at risk?

March 19, 2014  

Epstein-Barr and MS: meta-analysis

March 5, 2014  
Previous
29
30
31
32
33
Next

Browse by Topic

  • MS (414)
  • CLINICAL CASES IN MS (16)
  • EPILEPSY (36)
  • AAN 2025 (5)
  • BIOMARKERS IN MS (54)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • DMT prescribing in Canada – survey results posted on June 6, 2025
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • CLINICAL CASES IN MS: A 42 Y.O. WOMAN WITH A SEVERE RELAPSE ON DMF posted on June 2, 2025
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions